Current treatment of heart failure in the USA

Expert Review of Cardiovascular Therapy
Charles R SaltersThomas F Whayne

Abstract

Among elderly adults, the most common reason for hospitalization is heart failure. Understanding the treatment options for this complex syndrome is vital to the practice of contemporary medicine. Early recognition of patients at risk for developing heart failure and the stage-appropriate management of patients with established heart failure is paramount for optimal patient care. However, the vast array of therapeutic options currently available can seem daunting. It is the aim of this review to describe the framework for approaching heart failure patients so that the physician can provide the most appropriate therapies at each stage of the disease.

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Jun 2, 2001·The New England Journal of Medicine·UNKNOWN Beta-Blocker Evaluation of Survival Trial InvestigatorsPhilip W Lavori
Jan 5, 2002·The New England Journal of Medicine·J N CohnUNKNOWN Valsartan Heart Failure Trial Investigators
Nov 15, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Thomas R Cimato, Mariell Jessup
Dec 11, 2002·Circulation·Donald M Lloyd-JonesUNKNOWN Framingham Heart Study
Feb 18, 2003·JAMA : the Journal of the American Medical Association·Saif S RathoreHarlan M Krumholz
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 10, 2003·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Sandra ErbsRainer Hambrecht
Mar 18, 2004·JAMA : the Journal of the American Medical Association·Christopher O PhillipsHaya R Rubin
Jul 22, 2004·JAMA : the Journal of the American Medical Association·Véronique L RogerSteven J Jacobsen
Nov 10, 2004·The New England Journal of Medicine·Anne L TaylorUNKNOWN African-American Heart Failure Trial Investigators
Mar 9, 2005·The New England Journal of Medicine·John G F ClelandUNKNOWN Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators
Feb 28, 2006·Journal of Cardiac Failure·UNKNOWN Heart Failure Society Of America
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Jul 21, 2006·The New England Journal of Medicine·R Sacha BhatiaPeter P Liu
Nov 9, 2006·JAMA : the Journal of the American Medical Association·Francesca BursiVéronique L Roger
Dec 30, 2006·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 14, 2007·Archives of Internal Medicine·Robert J GoldbergFrederick A Spencer
Dec 19, 2007·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 3, 2008·Current Opinion in Cardiology·Aparajita DasAnita Deswal
Aug 2, 2008·Journal of the American College of Cardiology·Jing FangNora L Keenan
Nov 27, 2008·JAMA : the Journal of the American Medical Association·Adrian F HernandezLesley H Curtis
Nov 19, 2009·The New England Journal of Medicine·Mark S SlaughterUNKNOWN HeartMate II Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Cesare GridelliSteven E Schild
Pediatric Emergency Care
Kevin J Sullivan, Niranjan Kissoon
Heart Failure Clinics
Gautam V Ramani, Myung H Park
© 2021 Meta ULC. All rights reserved